Pages

Pages

Tuesday, 27 June 2023

8th Global Pharmaceutical Quality Summit 2023 Concludes in Mumbai

27 June 2023
-------------------------------

8th Global Pharmaceutical Quality Summit 2023 Concludes in Mumbai

Why in the News?

The 8th Global Pharmaceutical Quality Summit 2023 held in Mumbai garnered attention due to the presence of Dr. Mansukh Mandaviya, Union Minister for Chemicals and Fertilisers and Health & Family Welfare. His address highlighted India's significant role as a global pharmacy during the COVID-19 pandemic and emphasized the importance of quality, research and development, and innovation in the pharmaceutical industry.

Theme:

The theme of the 8th Global Pharmaceutical Quality Summit 2023 was "Patient Centricity: New Paradigm of Manufacturing and Quality." This theme aimed to explore innovative approaches to manufacturing and quality assurance in order to prioritize patient needs and enhance the overall healthcare experience.

Key Points:

  1. India's Role as a Global Pharmacy: Dr. Mandaviya emphasized that India played a crucial role as the "pharmacy for the world" during the COVID-19 pandemic by ensuring a continuous supply of quality medicines and vaccines to various countries. He highlighted India's ability to develop and deliver vaccines to 150 countries without any complaints regarding their quality.

  2. Indian Pharmaceutical Industry's Success: The Health Minister acknowledged the Indian pharmaceutical industry's achievements in terms of both quality and quantity. He stressed the importance of leveraging India's brand power and manpower to capitalize on the global demand for medicines and vaccines.
  3. Opportunities for Manufacturing and Innovation: Dr. Mandaviya urged the industry to seize the unique opportunity presented by the world's demand for Indian pharmaceutical products. He emphasized the need for quality, research and development, and innovation to meet the evolving healthcare challenges and maintain India's global leadership in the pharmaceutical sector.

No comments:

Post a Comment